ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1)

[Edit]

PMCA1; Plasma Membrane Calcium-Transporting ATPase 1; Plasma membrane calcium pump isoform 1

ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1)
ATP2B1 belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) CLIA Kit Customized Service Offer
n/a ELISA Kit for ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) CLIA Kit Customized Service Offer
n/a ELISA Kit for ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) CLIA Kit Customized Service Offer
n/a ELISA Kit for ATPase, Ca++ Transporting, Plasma Membrane 1 (ATP2B1) ELISA Kit Customized Service Offer
  1. "Complete primary structure of a human plasma membrane Ca2+ pump."J. Biol. Chem. 263:14152-14159(1988) [PubMed] [Europe PMC] [Abstract]
  2. "Molecular cloning of a plasma membrane calcium pump from human osteoblasts."J. Bone Miner. Res. 8:505-513(1993) [PubMed] [Europe PMC] [Abstract]
  3. "Structure of the gene encoding the human plasma membrane calcium pump isoform 1."J. Biol. Chem. 268:19717-19725(1993) [PubMed] [Europe PMC] [Abstract]
  4. "mRNAs for plasma membrane calcium pump isoforms differing in their regulatory domain are generated by alternative splicing that involves two internal donor sites in a single exon."Proc. Natl. Acad. Sci. U.S.A. 86:6908-6912(1989) [PubMed] [Europe PMC] [Abstract]
  5. "Study of calmodulin binding to the alternatively spliced C-terminal domain of the plasma membrane Ca2+ pump."Biochemistry 31:11785-11792(1992) [PubMed] [Europe PMC] [Abstract]
  6. "Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes."J. Biol. Chem. 268:25993-26003(1993) [PubMed] [Europe PMC] [Abstract]
  7. ErratumJ. Biol. Chem. 269:32022-32022(1994) [PubMed] [Europe PMC] [Abstract]
  8. "Human and rat intestinal plasma membrane calcium pump isoforms."Am. J. Physiol. 265:G917-G925(1993) [PubMed] [Europe PMC] [Abstract]
  9. "Primary structure of the cAMP-dependent phosphorylation site of the plasma membrane calcium pump."Biochemistry 28:4253-4258(1989) [PubMed] [Europe PMC] [Abstract]
  10. "Protein kinase C phosphorylates the carboxyl terminus of the plasma membrane Ca(2+)-ATPase from human erythrocytes."J. Biol. Chem. 266:9078-9085(1991) [PubMed] [Europe PMC] [Abstract]
  11. "Characterization of PISP, a novel single-PDZ protein that binds to all plasma membrane Ca2+-ATPase b-splice variants."Ann. N. Y. Acad. Sci. 986:461-471(2003) [PubMed] [Europe PMC] [Abstract]
  12. "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
  13. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  14. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  15. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  16. "POST, partner of stromal interaction molecule 1 (STIM1), targets STIM1 to multiple transporters."Proc. Natl. Acad. Sci. U.S.A. 108:19234-19239(2011) [PubMed] [Europe PMC] [Abstract]
  17. "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
  18. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  19. "Investigation of the Met-267 Arg exchange in isoform 1 of the human plasma membrane calcium pump in patients with essential hypertension by the amplification-created restriction site technique."J. Mol. Med. 75:62-66(1997) [PubMed] [Europe PMC] [Abstract]